{"SPADE_UN_11967": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_11967", "Peptide Name": "FK13-a1 (Derived from FK13)", "Source": "Synthetic construct", "Family": "Not found", "Gene": "Not found", "Sequence": "WKRIVRRIKRWLR", "Sequence Length": 13, "UniProt Entry": "No entry found", "Protein Existence": "Synthetic form", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram+", "Anti-Gram-"], "Target Organism": "[Ref.28161291] Gram-positive bacteria :Bacillus subtilis(KCTC 3068)(MIC=4 μM), Staphylococcus epidermidis(KCTC 1917)(MIC=4 μM), Staphylococcus aureus(KCTC1621)(MIC=2 μM);Gram-negative bacteria :Escherichia coli(KCTC 1682)(MIC=4 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=8 μM), Salmonella typhimurium(KCTC 1926)(MIC=2 μM)", "Hemolytic Activity": "[Ref.28161291] HC50>256 μM against human red blood cells", "Cytotoxicity": "[Ref.28161291] The cell viability of mouse macrophage RAW264.7 induced by FK13-a1 is 95.5%, 107.5%, 100.2%, 96.2%, 44.9% and 37.4% at peptide concentrations of 1.25, 2.5, 5, 10, 20 and 40 μM.The cell viablity of human keratinocyte HaCaT induced by FK1", "Binding Target": "Not found", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C87H148N32O14", "Mass": 1866.31, "PI": 12.0, "Net Charge": 7, "Hydrophobicity": -1.16, "Half Life": "Mammalian:2.8 hourYeast:3 minE.coli:2 min", "Function": "Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria", "Literature": [{"Title": "LL-37-derived membrane-active FK-13 analogs possessing cell selectivity, anti-biofilm activity and synergy with chloramphenicol and anti-inflammatory activity.", "Pubmed ID": "28161291", "Reference": "Biochim Biophys Acta Biomembr. 2017 May;1859(5)722-733. doi 10.1016/j.bbamem.2017.01.037.", "Author": "Rajasekaran G, Kim EY, Shin SY", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=28161291"}, {"Title": "LL-37-derived membrane-active FK-13 analogs possessing cell selectivity, anti-biofilm activity and synergy with chloramphenicol and anti-inflammatory activity", "Pubmed ID": "", "Author": "Rajasekaran G, Kim EY, Shin SY"}], "Frequent Amino Acids": "RIK", "Absent Amino Acids": "ACDEFGHMNOPQSTUY", "Basic Residues": 7, "Acidic Residues": 0, "Hydrophobic Residues": 6, "Polar Residues": 8, "Positive Residues": 7, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_02064", "Similarity": 1.0, "Sequence": "WLRRIGKGVKIIGGAALDHL"}, {"SPADE_ID": "SPADE_UN_28342", "Similarity": 1.0, "Sequence": "WLRRIGKGVKIIGGAALDHL"}, {"SPADE_ID": "SPADE_UN_05499", "Similarity": 1.0, "Sequence": "RWLRIRKVY"}]}}}